Deal of the Day — limited-time pharmacy picks!
Easyfive TT 0.5ml Vaccine

Easyfive TT 0.5ml Vaccine

Prescription requiredRx Required
Refrigerated 2–8°C · Online payment only

Salt Composition: Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus

Expiry Date: 01/2028

Special offer

Buy at $16.13

$16.13

Inclusive of all taxes

▼

1 Vial in a Pack

About The Product

Diphtheria, Haemophilus influenzae type b, Hepatitis-B, Pertussis, and Tetanus, Conjugate Vaccine

Easyfive TT 0.5 ml is a vaccine that protects against five diseases (pentavalent), namely tetanus, diphtheria, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B. It contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response. Easyfive TT 0.5 ml vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age. It is an adsorbed liquid formulation that is ready to use. Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems. Also, let the medical healthcare team know if your child is allergic to any medicine.


Uses

Prevention of Pertussis
Prevention of Tetanus
Prevention of Haemophilus influenzae Type b disease
Prevention of Diphtheria
Prevention of Hepatitis B infection

Side Effects

  • Undesired symptoms or responses vary from individual to individual as the human body reacts differently to the Easyfive TT 0.5ml Vaccine, but they disappear naturally within a few days as the body adjusts to the vaccine, which requires no medical attention.
  • In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
  • Some of the common side effects of the Easyfive TT 0.5ml Vaccine are: Fatigue Headache Fever loss of appetite Nausea Pain, redness or swelling at injection site anaphylaxis in some severe cases.

How To Use

  • The Easyfive TT 0.5 ml vaccine is given into the deltoid muscle of the upper arm.
  • It is an intramuscular injection.
  • Do not use the same injection or syringe for another vaccine, as there is a chance of interaction.
  • Always check the vial of vaccine before using it for discoloration or any kind of particulate matter, and shake well for uniform mixing of the product.
  • Easyfive TT 0.5 ml vaccine is given routinely to infants in three doses at 6, 10, and 14 weeks of age.
  • It is an adsorbed liquid formulation that is ready to use.
  • Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems.
  • Also, let the medical healthcare team know if your child is allergic to any medicine.

How It Works

Easyfive TT 0.5 ml is a vaccine that protects against five diseases (pentavalent), namely tetanus, diphtheria, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and hepatitis B. It contains the toxoid of tetanus, diphtheria, the surface antigen of hepatitis B, and the whole cell of pertussis bacteria, all of which are adsorbed on an adjuvant made of aluminum to trigger the immune response.

When Easyfive TT 0.5ml Vaccine is given to an individual then it stimulates the immune system to produce specific antibodies against the toxins, but doesn’t cause disease. These antibodies and memory cells formed after taking the injection identify and counteract the toxins and generate memory for it, and neutralize it with a stronger immune response upon subsequent exposure within a few hours.

This provides immunity within 2 to 4 weeks and for many years.

Safety Advice

Alcohol
Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Easyfive TT 0.5 ml vaccine, as per the research.
Pregnancy
The Easyfive TT 0.5 ml vaccine should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. The Easyfive TT 0.5 ml vaccine is generally not safe to take during pregnancy as it is meant for children and infants. Pregnant women should receive Tdap vaccines to protect the developing baby from pertussis.
Breast Feeding
The Easyfive TT 0.5 ml vaccine can be taken while breastfeeding after discussion with your doctor. It is generally considered safe, and there is no clear evidence found in the clinical data to harm the baby.
Driving
Driving after taking the Easyfive TT 0.5 ml vaccine does not affect or interfere with driving ability or disturb while operating machinery. There are no records found that show it affects the coordination or mental alertness. However, if you get a fever or dizziness after the injection, avoid driving until you feel better.
Kidney
The Easyfive TT 0.5 ml vaccine is considered safe for people with kidney problems, including individuals on dialysis. The Easyfive TT 0.5 ml vaccine is considered safe for people with kidney problems, including individuals on dialysis. Although the immune response may be reduced in patients having kidney problems but it is generally recommended to take the vaccine after discussing with your doctor or medical experts.
Liver
The Easyfive TT 0.5 ml vaccine is generally considered beneficial and safe for people with chronic liver disease, and vaccination is strongly recommended for people who are at high risk of getting severe tetanus, Diphtheria, and Pertussis.

FAQs

Easyfive TT 0.5ml Vaccine is given to infants in 3 doses starting from 1st dose given after 6 weeks, 2nd dose after 10 weeks and 3rd week after 14 weeks.

Reference

Gandhi, D. J., Dhaded, S.

M., Ravi, M. D., Dubey, A.

P., Kundu, R., Lalwani, S. K.,& Dhingra, M.

S. (2024).

Safety, immune lot-to-lot consistency, and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants. Human Vaccines & Immunotherapeutics, 12(4), 946-954.

Gatchalian, S., Palestroque, E., De Vleeschauwer, I., Han, H. H., Poolman, J., Schuerman, L., & Boutriau, D.

(2025). The development of a new heptavalent diphtheria–tetanus–whole cell pertussis–hepatitis B B-Haemophilus influenzae type b–b-b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.

International Journal of Infectious Diseases, 12(3), 278-288. Rao, R., Dhingra, M.

S., Bavdekar, S., Behera, N., Daga, S. R., Dutta, A.

K. & Rajamani, A. M.

(2025). A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix+ Hiberix (Lyo) in Indian infants administered according to the EPI schedule.

Human vaccines, 5(6), 425-429. Sharma, H.

J., Yadav, S., Lalwani, S. K., Kapre, S.

V., Jadhav, S. S., Chakravarty, A., & Verma, V.

(2024). Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+ Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children.

Human vaccines, 7(4), 451-457. Sharma, H., Yadav, S., Lalwani, S., Gupta, V., Kapre, S., Jadhav, S., & Palkar, S.

(2023). A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants.

Vaccine, 29(13), 2359-2364.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026